150 related articles for article (PubMed ID: 7796945)
1. Manipulation of the cellular binding properties of poliovirus: implications for non-target effects of recombinant vaccines.
Whelan SP; Evans D; Almond JW
Dev Biol Stand; 1995; 84():129-36. PubMed ID: 7796945
[No Abstract] [Full Text] [Related]
2. Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus.
Georgescu MM; Delpeyroux F; Crainic R
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2343-8. PubMed ID: 7561775
[TBL] [Abstract][Full Text] [Related]
3. Vaccines based on recombinant antigen strategies.
Minor P
Dev Biol (Basel); 2001; 105():189-94. PubMed ID: 11763327
[No Abstract] [Full Text] [Related]
4. Antigen chimeras of poliovirus.
Burke KL; Almond JW; Evans DJ
Prog Med Virol; 1991; 38():56-68. PubMed ID: 1647044
[No Abstract] [Full Text] [Related]
5. Antigenic hybrids of poliovirus.
Hogle JM
Nature; 1988 Mar; 332(6159):13-4. PubMed ID: 2831454
[No Abstract] [Full Text] [Related]
6. Murine neurovirulence studies with a chimeric poliovirus: in vivo generation of a mutant base-paired stable attenuated poliovirus.
Lee C; Young C
Microb Pathog; 1998 Oct; 25(4):215-25. PubMed ID: 9817825
[TBL] [Abstract][Full Text] [Related]
7. Infectious vaccines.
Ross DW
Arch Pathol Lab Med; 1998 Jan; 122(1):100-1. PubMed ID: 9448028
[No Abstract] [Full Text] [Related]
8. Engineering poliovirus as a vaccine vector for the expression of diverse antigens.
Andino R; Silvera D; Suggett SD; Achacoso PL; Miller CJ; Baltimore D; Feinberg MB
Science; 1994 Sep; 265(5177):1448-51. PubMed ID: 8073288
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
[TBL] [Abstract][Full Text] [Related]
10. Inactivated vaccines based on alternatives to wild-type seed virus.
Chumakov K; Dragunsky E; Ivshina A; Enterline J; Wells V; Nomura T; Gromeier M; Wimmer E
Dev Biol (Basel); 2001; 105():171-7. PubMed ID: 11763325
[No Abstract] [Full Text] [Related]
11. [Pandora's box opens up again. First fully synthetic poliovirus presented].
Hassler D; Braun R; Kimmig P; Schwarz TF
Dtsch Med Wochenschr; 2002 Aug; 127(33):1678. PubMed ID: 12243125
[No Abstract] [Full Text] [Related]
12. A cassette vector for the construction of antigen chimaeras of poliovirus.
Burke KL; Evans DJ; Jenkins O; Meredith J; D'Souza ED; Almond JW
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2475-9. PubMed ID: 2476528
[TBL] [Abstract][Full Text] [Related]
13. Antigenic potency of inactivated poliovirus vaccines.
Moynihan M; Petersen I
Dev Biol Stand; 1981; 47():129-33. PubMed ID: 6262143
[TBL] [Abstract][Full Text] [Related]
14. [Genetic determinants of neurovirulence and attenuation of poliovirus].
Azol VI
Mol Gen Mikrobiol Virusol; 1988 Jan; (1):3-9. PubMed ID: 2833691
[TBL] [Abstract][Full Text] [Related]
15. Approaches to the construction of new candidate poliovirus type 3 vaccine strains.
Almond JW; Stone D; Burke K; Skinner MA; Macadam AJ; Wood D; Ferguson M; Minor PD
Dev Biol Stand; 1993; 78():161-9; discussion 169-70. PubMed ID: 8388827
[TBL] [Abstract][Full Text] [Related]
16. International workshop: 'poliovirus attenuation: molecular mechanisms and practical aspects'. 9-10 December 1991, Holiday Inn, Bethesda, MD, U.S.A.
Ehrenfeld E
Biologicals; 1992 Jun; 20(2):167-9. PubMed ID: 1327006
[No Abstract] [Full Text] [Related]
17. An overview of vaccine vectors.
Dorner F
Dev Biol Stand; 1995; 84():23-32. PubMed ID: 7796959
[No Abstract] [Full Text] [Related]
18. Poliovirus and its cellular receptor: a molecular genetic dissection of a virus/receptor affinity interaction.
Solecki D; Gromeier M; Harber J; Bernhardt G; Wimmer E
J Mol Recognit; 1998; 11(1-6):2-9. PubMed ID: 10076797
[TBL] [Abstract][Full Text] [Related]
19. Recombinant polioviruses as candidate strains of oral poliovaccines.
Nomoto A
Dev Biol Stand; 1995; 84():123-7. PubMed ID: 7796944
[No Abstract] [Full Text] [Related]
20. Attenuation and reversion of the Sabin vaccine strains of poliovirus.
Minor PD
Dev Biol Stand; 1993; 78():17-26. PubMed ID: 8388828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
